Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Advances in technologies used to assess immune function in myeloma

Heinz Ludwig, MD, Wilhelminen Cancer Research Institute, Vienna, Austria, discusses the importance of assessing immune function in multiple myeloma, commenting on recent advances made in technologies used to evaluate the immune system in this disease. Prof. Ludwig also shares insights into the value of single-cell analysis and how this may be used to study clonal evolution in multiple myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.